FDA Approves New Diagnostic Imaging Agent to Detect Rare Neuroendocrine Tumors

Breaking news on June 1, 2016 from the U.S. Food and Drug Administration! The FDA has approved NETSPOT, “the first kit for the preparation of gallium Ga 68 dotatate injection, a radioactive diagnostic agent for positron emission tomography (PET) imaging.”   Read more from the FDA and Read more from Advanced Acclerator Applications

Print Friendly, PDF & Email